Andrew Bauer Research Program
Led by Andrew J. Bauer researchers in the Bauer Research Program are focused on refining and improving the effectiveness, safety and quality of life outcomes of existing therapies that are used to treat pediatric thyroid nodules and differentiated thyroid cancer (DTC). The long-term goal of the research conducted in this program is to refine treatment guidelines and best practices to minimize treatment-related late effects and improve medical and quality of life outcomes for children and adolescents with thyroid nodules and DTC.
Ongoing Research
Ongoing Research
Selected Publications
DICER1 mutations and differentiated thyroid carcinoma: Evidence of a direct association. J Clin Endocrinol Metab. 2015 Nov 10:jc20152169.
Rutter MM, Jha P, Schultz KA, Sheil A, Harris AK, Bauer AJ, Field AL, Geller J, Hill DA.
Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015 Jul;25(7):716-59.
Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force.
Pediatric thyroid carcinoma in patients with graves disease: The role of ultrasound in selecting patients for definitive therapy. Horm Res Paediatr. 2015 Apr 15.
Kovatch KJ1, Bauer AJ, Isaacoff EJ, Prickett KK, Adzick NS, Kazahaya K, Sullivan LM, Mostoufi-Moab S.
